|
Mountain U.S. Biotech News. Service for global professionals. Constantly updated news and information about Mountain U.S. Biotech.
Latest Mountain U.S. Biotech News
- BUYINS.NET: WMT, ECA, CPA, BPHX, HLCS, VLCCF Expected To Be Lower After Earnings Releases on Thursday 9 Nov 2009 19:35 GMT
... Nov 09, 2009 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET ... Fort Worth resource areas located in Wyoming, Colorado, Texas, and Utah, the United States. EnCana Corporation also has ...
- www.standoutstocks.com: Stocks That Stand Out For Nov. 9th, 2009 Are ZAGG, JAZZ, NNVC, KDKN 9 Nov 2009 19:35 GMT
... Nov 09, 2009 (M2 PRESSWIRE via COMTEX) -- www.StandoutStocks.com: ... Located in the University Mall in Orem, Utah, the inline store is an expansion of ... main prospect is located in the northeast New Mexico. Through our private subsidiary, Cougar Energy, Inc., ...
- Capstone Therapeutics Announces Third Quarter 2009 Financial Results 9 Nov 2009 13:33 GMT
... Capstone Therapeutics , trade name of OrthoLogic Corp. (the "Company"), today announced financial results for ... (trade name of OrthoLogic Corp.) is a biotechnology company committed to developing a pipeline of ... Chrysalin. Capstone's corporate headquarters are in Tempe, Arizona, U.S.A. For more information, please visit the ...
- The Medical Industry Grumbles, but It Stands to Gain 9 Nov 2009 11:52 GMT
... The Medical Industry Grumbles, but It Stands to Gain ... Senate majority leader, Harry Reid, Democrat of Nevada, has also signaled that he intends to ... to fear. In a victory for the biotechnology drug industry, the House bill would give ...
- Newsweek partners with oil lobby to raise ad cash 9 Nov 2009 23:10 GMT
... In September, I wrote a post “ piece by ... then-API President Red Cavaney, Rep. Jim Matheson (R-Utah), Sen. Lisa Murkowski (R-Alaska), and a under the ... water as an environmental concern. Agriculture and biotechnology company Monsanto Co. and Black & Veatch, ...
- BiomedReports: News and FDA Updates for Ardea (Nasdaq:RDEA), Covidien (NYSE:COV), PharMerica (NYSE:PMC) 9 Nov 2009 09:36 GMT
... On 06/11/09, Ardea Biosciences, Inc. (Nasdaq:RDEA), a biotechnology company focused on the development of small-molecule ... tender offer through its subsidiary, Transformer Delaware Corp., to purchase all of the outstanding shares ... Suisse 18th Annual Healthcare Conference in Phoenix, Arizona, on Wednesday, November 11, 2009, at 10:00 ...
- Worldwide Clinical Research sells to Clinipace 9 Nov 2009 18:33 GMT
... , based in Overland Park, has sold to clinical ... Worldwide Clinical also had offices in Virginia, Colorado and Texas, and in Sao Paolo, Brazil; ... services for clinical research studies for medium-sized biotech companies, Geiger said. Clinipace COO Chris Porter ...
- Researchers complete draft genome sequence for cassava 9 Nov 2009 18:14 GMT
... cassava A team of academic, government and industry researchers has completed a first draft of ... a $1.3 million grant to University of Arizona researchers who will lead an international consortium ... will provide new tools to breeders and biotechnologists to speed up the improvement of cassava ...
- TRACON Pharmaceuticals Announces Upcoming Presentation of Clinical Data on TRC102, a Selective Inhib 9 Nov 2009 13:33 GMT
... 2009 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, a biotechnology company that develops targeted therapies for oncology and ... Presenter: Michael Gordon, MD, Premiere Oncology of Arizona Date and Time: Tuesday Nov 17, 2009, ...
- TRACON Pharmaceuticals Announces Upcoming Presentation of Clinical Data on TRC102, a Selective Inhibitor of DNA Base Excision Repair and Chemotherapy Resistance 9 Nov 2009 13:34 GMT
... 2009 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, a biotechnology company that develops targeted therapies for oncology and ... Presenter: Michael Gordon, MD, Premiere Oncology of Arizona Date and Time: Tuesday Nov 17, 2009, ...
- TRACON Pharmaceuticals Announces Upcoming Presentation of Clinical Data on TRC102, a Selective Inhibitor of DNA Base Ex 9 Nov 2009 14:16 GMT
... 2009 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, a biotechnology company that develops targeted therapies for oncology and ... Presenter: Michael Gordon, MD, Premiere Oncology of Arizona Date and Time: Tuesday Nov 17, 2009, ...
- Colorado Bioscience Association Recognizes the Best of Colorado's Bioscience Industry 5 Nov 2009 14:31 GMT
... Colorado Bioscience Association Recognizes the Best of Colorado's ... of the new Colorado Initiative in Molecular Biotechnology (CIMB) and Investigator for the Howard Hughes ...
- StockProfiler.US: HearAtLast Holdings, Inc. & Sinovac Biotech Ltd. 4 Nov 2009 09:37 GMT
... StockProfiler.US: HearAtLast Holdings, Inc. & Sinovac Biotech Ltd. Wed. November 04, 2009; Posted: 04:10 ... news link. HearAtLast Holdings, Inc. is a Nevada corporation that owns and operates its wholly owned ...
- Reflect Scientific Consolidates Cryometrix Product Line to Montana Facility 6 Nov 2009 12:16 GMT
... ), a provider of diverse products and services for the ... of its Cryometrix operation into its Bozeman, Montana facility. It has been a goal of Reflect ... Scientific. Reflect Scientific, Inc., based in Orem, Utah, develops and markets innovative, proprietary technologies in ...
- Abraxis Health Dedicates State of the Art Nanotechnology & Biologics Facility in Phoenix, Arizona 5 Nov 2009 14:14 GMT
... Art Nanotechnology & Biologics Facility in Phoenix, Arizona -Flagship Facility Compliant with Worldwide Nanobiologics Regulatory ... Facility Compliant with Worldwide Nanobiologics Regulatory Requirements- --(BUSINESS WIRE)--Nov 5, 2009 - Abraxis Health, a ... Abraxis BioScience is a fully integrated global biotechnology company dedicated to the discovery, development and ...
Powered by 
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
|
a digital news provider
>
All Mountain U.S. News sections
latimes.com:
cnn.com:
nytimes.com:
reuters.com:
bbc.co.uk:
wsj.com: